Stay updated on Ibrutinib & PD-1 Blockade in High Risk CLL Clinical Trial

Sign up to get notified when there's something new on the Ibrutinib & PD-1 Blockade in High Risk CLL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ibrutinib & PD-1 Blockade in High Risk CLL Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error, replacing the typical study record content with an access-denied message. This indicates restricted access to the page rather than a substantive update to the study information.
    Difference
    18%
    Check dated 2026-09-21T00:57:49.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    Footer text updated to Revision: v3.6.6. Sponsor/branding lines referencing Moffitt Cancer Center and 'Helpful Links Provided by' were removed.
    Difference
    0.2%
    Check dated 2026-08-30T22:36:53.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The page revision has been updated to v3.6.5, replacing the previous v3.6.4. This is a metadata update and does not modify the study information or content shown on the page.
    Difference
    0.1%
    Check dated 2026-08-09T09:21:14.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.6.4, replacing v3.6.3. This indicates a minor software/version update with no changes to study details or how to participate.
    Difference
    0.1%
    Check dated 2026-07-25T18:03:35.000Z thumbnail image
  7. Check
    93 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.2 to v3.6.3 in the footer. This represents a minor site version update and does not alter any study details or page content.
    Difference
    0.1%
    Check dated 2026-07-04T08:22:37.000Z thumbnail image
  8. Check
    100 days ago
    Change Detected
    Summary
    A new Revision tag shows v3.6.2 on the page, replacing v3.6.0, indicating a minor update to the page template or backend. No visible study information or actions appear to be changed.
    Difference
    0.1%
    Check dated 2026-06-27T06:43:42.000Z thumbnail image

Stay in the know with updates to Ibrutinib & PD-1 Blockade in High Risk CLL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ibrutinib & PD-1 Blockade in High Risk CLL Clinical Trial page.